AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04945876 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital follow-up
Description: Participants will receive:~One session of individual exercise and diet guidance focusing on goals and motivation.~An activity tracker and instructions on how to use it both for motivation, daily activity tracking, logging of specific exercise and using the wristbands heart rate monitor to control intensity level during exercise.~Monthly digital follow-up to provide support and address questions and goals regarding nutrition, daily energy expenditure and exercise.~Opportunity to send sms with questions regarding nutrition and exercise. Participants who are malnourished, or at risk of malnutrition will be offered a total of two hours of additional individualized, digital guidance on nutrition as needed.
Study NCT06630416 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06630416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Given IV
Study NCT06628999 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Training
Description: 16-week training protocol focused on visual training designed for ameliorating cognitive performance and physical fitness
Study NCT06628999 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: 16-week of active lifestyle based on healthy habits
Study NCT06628999 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Training-detraining
Description: 8-week training protocol focused on visual training designed for ameliorating cognitive performance and physical fitness, followed by 8 week with no specific training protocol
Study NCT06320756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wysa in Hindi
Description: Wysa in Hindi is a blended digital mental health intervention
Study NCT06320756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual and group sessions on topics like motivation, coping, wellbeing
Description: Individual and group sessions on wellbeing, coping, and motivation with the diabetes educator team
Study NCT06320756 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individual and group sessions on topics like motivation, coping, wellbeing
Description: Individual and group sessions on wellbeing, coping, and motivation with the diabetes educator team
Study NCT06551129 — intervention group
Intervention type: DRUG
Intervention: Mavacamten
Description: As prescribed by treating physician
Study NCT05690035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab & Fruquintinib
Description: combinational treatment of Tislelizumab and Fruquintinib until PD, intolerable toxicity, death or withdrawal of informed consent
Study NCT04940325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-1062a
Description: First infusion for 90 minutes and then infusion duration can be decreased to 30 minutes if participant didn't experience infusion related reactions (IRR)
Study NCT06428851 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laser therapy
Description: Shoulder girdle muscles were lasered for 5 minutes a day, 3 days a week, total of 4 weeks.
Study NCT06428851 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuromuscular electrical nerve stimulation
Description: Neuromuscular electrical nerve stimulation was applied to the shoulder flexor and abductor muscles for 20 minutes a day 5 days a week, total of 4 weeks.
Study NCT06428851 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Classical physical therapy exercises were applied according to the patient's needs and neurologic level. These exercises are determined by the physiotherapist according to the functional status of the patient and consist of passive, passive assisted, active range of motion exercises, stretching and strengthening exercises, mobilization exercises 5 days a week for 1 hour, total of 4 weeks.
Study NCT06126328 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Materna Prep Device
Description: Subjects are treated with Materna Prep Device prior to vaginal delivery
Study NCT06416033 — intervention group
Intervention type: PROCEDURE
Intervention: Serum Irisin
Description: Measurement of plasma irisin level in leprosy patients.
Study NCT05739630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone liposome
Description: Mitoxantrone liposomes with 36mg/m2 and Bu 3.2mg/kg -5 to -4, Flu 30mg/m2 -12 to -9, Ara-C 1.5g/m2 -12 to -9，CTX 15mg/kg/d -3 to -2, was used as conditioning regimen, Post Transplant Cyclophosphamide 50 mg/kg IV daily on days +3 and +4.
Study NCT06480409 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR Mindfulness and Stress Reduction Program
Description: Intervention Procedure:~Duration and Frequency: Participants will engage in 15-minute VR relaxation sessions, held five times a week over a period of one month.~VR Content: The VR sessions will feature high-quality 360° videos with therapeutic audio, including guided relaxation, calming music, and nature sounds.~Physiological Monitoring: Throughout the sessions, participants' physiological responses will be monitored using Polar H-10 sensors to measure heart rate variability (HRV), providing data on autonomic nervous system activity.~Psychological Assessment: Participants will complete the Perceived Stress Scale (PSS-10) before and after the intervention to evaluate changes in stress levels.~Cybersickness Monitoring: The occurrence of any adverse effects, such as cybersickness, will be monitored and recorded.
Study NCT05829174 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation and cognitive modules
Description: Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Study NCT05829174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation and cognitive modules
Description: Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Study NCT05829174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral module: Starting on Time and Planning Realistically
Description: Learning of realistic planning, and timely starting of work.
Study NCT05829174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral module: Working Time Restriction
Description: Restriction of allowed time for work, and gradual increase of allowed time, if previous time windows where effectively used.
Study NCT05829174 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral module: Pomodoro Time Management Technique
Description: Working in 25 minutes time intervals
Study NCT05739630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATG
Description: Control group:the conditioning regimen involved Ara-C 2g/m2 q12h -8, BU 3.2 mg/kg -7 to -5,CTX 1.8 g/m2 -4 to -3, to prevent GVHD, MTX 15mg/m2 +1d, 10mg/m2 +3,+6,+11,CsA 3mg/kg/d from -8d,MMF 1g q12h from -8d， ATG 2.5mg/kg/d -5 to -2.
Study NCT06449898 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: hemodialysis group
Description: Data were collected from patients undergoing treatment at a hemodialysis center in Kırşehir. Participants were informed about the study objectives and provided written consent. Data collection took approximately 20-30 minutes per participant and included a face-to-face interview where socio-demographic and clinical information was recorded.
Study NCT05423054 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Description: * Patients will be positioned on their back while their knees will be flexed.~* Each patient will receive a 15-minute abdominal massage intervention half an hour before enteral feeding twice per day and the interval between two massages is 2 hours for consecutive 3 days.~* The PR will be standed on the right side of the patient during the massage practice.~* The abdominal massage technique will be delivered to each patient in four consecutive strokes including stroking, effleurage, kneading and vibration.
Study NCT05077527 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Axicabtagene Ciloleucel
Description: Given IV
Study NCT05077527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT05077527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT05504395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSTI-500
Description: Single 10 mg capsule
Study NCT06073847 — intervention group
Intervention type: DRUG
Intervention: Fedratinib
Description: According to the approved label
Study NCT06300840 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BalanceBelt
Description: The vibrotactile belt (i.e., Elitac BalanceBelt®) supports patients with severe balance disorders by substituting the missing balance information with vibrations (haptic feedback).
Study NCT06383767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ESG401
Description: IV infusion on day 1,8, and 15 of each 28 day cycle
Study NCT06383767 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eribulin, capecitabine, gemcitabine or vinorelbine (Treatment of Physician's Choice)
Description: Eribulin, capecitabine, gemcitabine or vinorelbine
Study NCT06300840 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: BalanceBelt
Description: The vibrotactile belt (i.e., Elitac BalanceBelt®) supports patients with severe balance disorders by substituting the missing balance information with vibrations (haptic feedback).
Study NCT06196528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WristArt implant
Description: implantation of the WristArt implant
Study NCT06265051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirofiban
Description: After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Tirofiban 5μg/kg was administered intravenously through the catheter artery at a rate of 1ml/min, followed by an intravenous infusion of 0.1μg/(kg·min) for 24 hours. Standard medical treatment was administered after the surgery.
Study NCT06265051 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Saline placebo was administered in the same manner as tirofiban group. Standard medical treatment was administered after the surgery.
Study NCT06341764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab 1120 mg
Description: Durvalumab 1120 mg day 1 i.v
Study NCT06341764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab 1500 mg
Description: Durvalumab i.v. at 1500 mg once every 4 weeks
Study NCT06341764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab i.v. at 300 mg
Description: Single dose
Study NCT06341764 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cisplatin (CDDP) 25 mg/mq i.v
Description: Four cycles
Study NCT06341764 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 1000 mg/mq i.v.
Description: Days 1 and 8 every 21 days
Study NCT05554575 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BT-007 CD7 CAR-T cells
Description: T cells purified from the peripheral blood mononuclear cell (PBMC) of subjects or subjects' relatives which depend on their conditions, transduced with 4-1BB/CD3ζ lentiviral vector, expanded in vitro for future administration.
Study NCT05088395 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 24 months.
Study NCT05088395 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biopsy
Description: If a specific tumor sample is required, it will be collected only once during the study
Study NCT05213000 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 90 minute exercise session
Study NCT06102915 — intervention group
Intervention type: DRUG
Intervention: Rocuronium Bromide 10 MG/ML
Description: Comparative
Study NCT06102915 — intervention group
Intervention type: DRUG
Intervention: Nimbex 10 MG in 5 ML Injection
Description: Comparative
Study NCT05844397 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: WaveLight EX500 Excimer Laser System
Description: LASIK Refractive Surgery Using Contura with Phorcides
Study NCT05844397 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VisuMax Surgical Laser
Description: SMILE Refractive Surgery
Study NCT06188585 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UI-EWD
Description: Hemostatic powder administered at index endoscopy
Study NCT06188585 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional therapy
Description: Conventional endoscopic therapy (bipolar electrocoagulation or clips, with or without epinephrine injection) administered at index endoscopy
Study NCT05794087 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clean Air
Description: Subjects will be exposed to clean air for 3 hours.
Study NCT05794087 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ozone
Description: Subjects will be exposed to 0.2 ppm ozone for 3 hours.
Study NCT05262972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conservatory treatment
Description: Personalized plantar orthosis
Study NCT05262972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Innovate treatment
Description: Personalized plantar orthosis + percutaneous electrolysis
Study NCT05189587 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial electrical stimulation (TES)
Description: Transcranial electrical stimulation (tES) is a noninvasive brain stimulation technique that passes an electrical current through the cortex of the brain to alter brain function. The electrical current is applied to an individual's scalp usually via two or more electrodes, and whilst a large amount of the current is conducted between electrodes through soft tissue and skull (Vöröslakos et al. 2018), a portion of the current penetrates the scalp and is conducted through the brain, where it can alter neuronal excitability. By altering the activity of brain regions involved with a behaviour of interest, investigators can observe the resulting behavioral changes and so establish a causal link between the two (Reed et al. 2018).
Study NCT05189587 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial electrical stimulation (TES)
Description: Transcranial electrical stimulation (tES) is a noninvasive brain stimulation technique that passes an electrical current through the cortex of the brain to alter brain function. The electrical current is applied to an individual's scalp usually via two or more electrodes, and whilst a large amount of the current is conducted between electrodes through soft tissue and skull (Vöröslakos et al. 2018), a portion of the current penetrates the scalp and is conducted through the brain, where it can alter neuronal excitability. By altering the activity of brain regions involved with a behaviour of interest, investigators can observe the resulting behavioral changes and so establish a causal link between the two (Reed et al. 2018).
Study NCT05980468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music therapy
Description: Music intervention sessions will be applied to each participant for 5 weeks, 3 days a week, 20 minutes per session.
Study NCT05988229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toolkit to improve discharge equity
Description: Linguistically appropriate discharge teaching aids: a medication calendar, pictographics added to the after visit summary (AVS), and an audio recording of the discharge teaching.
Study NCT04993560 — intervention group
Intervention type: BIOLOGICAL
Intervention: BBIBP-CorV
Description: Inactivated virus COVID-19 vaccine
Study NCT04993560 — intervention group
Intervention type: BIOLOGICAL
Intervention: BNT162b2
Description: mRNA-based COVID-19 vaccine
Study NCT05108506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No Strict need to void following surgery
Description: Certain patient will be randomized without a strict need to void prior to discharge following surgery.
Study NCT05108506 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Strict need to void following surgery
Description: Certain patient will be randomized with a strict need to void prior to discharge following surgery.
Study NCT05703802 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Procalcitonin-variants ELISA-Assay
Description: Observational study measuring procalcitonin-variants in different patient collectives by obtaining 3 blood collection tubes per patient.
Study NCT05813210 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Exercise in combination with biomarkers and pharmacological stress CMR test
Description: A bicycle ergometry combined with pharmacoligical stress test is performed. High sensitive Troponin is taken before and after the stress test.
Study NCT05813210 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Exercise in combination with biomarkers and pharmacological stress CMR test
Description: A bicycle ergometry combined with pharmacoligical stress test is performed. High sensitive Troponin is taken before and after the stress test.
Study NCT05714020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Real rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) is applied to the primary motor cortex. The protocol consists of 15 minutes of 10Hz stimulation, 10 seconds on, 20 seconds off, at 90% RMT, for a total of 3000 pulses.
Study NCT05714020 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: A sham coil is also used to mimic the clicking sound of the transcranial magnetic coil and skin stimulation.
Study NCT04863235 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Eight week behavioural change program aimed to increase physical activity plus information on general health topics among individuals with prediabetes.
Study NCT04863235 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: Eight week behavioural change program plus a self-compassion intervention aimed to increase physical activity among individuals with prediabetes.
Study NCT04308304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1942
Description: MK-1942 1 mg, 5 mg, and/or 10 mg capsules taken twice daily (BID) by mouth.
Study NCT04308304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil
Description: Donepezil 5 mg and/or 10 mg tablets taken once daily (QD) by mouth.
Study NCT04308304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Donepezil
Description: Donepezil 5 mg and/or 10 mg tablets taken once daily (QD) by mouth.
Study NCT04308304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule matched to MK-1942 taken BID by mouth.
Study NCT04674202 — intervention group
Intervention type: OTHER
Intervention: Phone interview
Description: The participant will have 2 phone interview in which they will be asked about their knowledge of direct oral anticoagulants.
Study NCT05180617 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Music therapy participants will interact both musically and verbally with the therapist and will be given a range of both electronic and acoustic instruments to choose from. Music therapy sessions will be based upon music improvisation, and as such participants are not required to have any previous instrument or other music experience and be invited to improvise freely using the instruments. The music therapist will accompany participants in the improvisation. This provides participants with an opportunity to connect with emotions and feelings connected to hidden psychic material. Following improvisations, the therapist and client will identify these moments of interest which can be further explored either verbally or through further improvisation. The music created within sessions will be recorded and participants can take a copy of the recordings home and it will be used in the therapeutic monitoring and analysis of sessions.
Study NCT04841135 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Multiomics quantification
Description: One time blood, stool and urine samples will be taken.
Study NCT04841135 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Polysomnography
Description: Facultative polysomnography
Study NCT04368806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JointStem
Description: Autologous Adipose tissue derived Mesenchymal Stem Cells (AdMSC)
Study NCT04368806 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control
Description: Normal Saline with autologous Serum
Study NCT05152160 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical Cord Mesenchymal Stem Cell Therapy
Description: Umbilical Cord Mesenchymal Stem Cell Therapy
Study NCT05486338 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hybrid Argon Plasma Coagulation (HAPC)
Description: Gastric mucosal ablation is an endoscopic procedure which uses argonplasma coagulation in combination with submucosal injection to achieve selective ablation to the gastric mucosa and preventing thermal damage to the muscle layer.